Skip to content

Effect of moxibustion with different amount of moxibustion on the positive reaction point of spleen meridian in treating primary dysmenorrhea

Effect of heavy moxibustion of Doucai on cellular microcirculation in patients with primary dysmenorrhea

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057330
Enrollment
Unknown
Registered
2022-03-08
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea

Interventions

Observation group:Moxibustion 6 zhuang, about 30 minutes
The control group A:Moxibustion 9 zhuang, about 45 minutes
The control group B:Moxibustion 3 zhuang, about 15 minutes

Sponsors

Hebei University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of primary dysmenorrhea; 2. Childless women aged 18-30; 3. The menstrual cycle was basically normal (28+-7 days); 4. The course of the disease ranges from 6 months to 15 years 5. VAS scale score >= 40mm; 6. No pain medication or other treatment was taken in the 24 hours prior to the trial.

Exclusion criteria

Exclusion criteria: 1. Through B ultrasonic and gynecological examination confirmed as a result of endometriosis pelvic inflammation adenomyopathy, and other diseases or other factors caused by secondary dysmenorrhea; 2. Irregular menstrual cycle; 3. Combined with the medical history, patients with serious life-threatening primary diseases such as cardiovascular, cerebrovascular, liver, kidney, and hematopoietic system, as well as other diseases unsuitable for acupuncture and moxibustion, such as mental patients; 4. Moxibustion site soft tissue damage, ulceration scar calluses, and other skin problems are not suitable for moxibustion.

Design outcomes

Primary

MeasureTime frame
Visual analog scoring;Uterine microcirculation;Rate of pain relief after moxibustion treatment (proportion of patients with >=50% reduction in VAS after treatment compared to baseline);

Secondary

MeasureTime frame
Cox Menstrual Symptom Scale;Cox Menstrual Symptom Scale;Self-rating depression scale;

Countries

China

Contacts

Public ContactJun Liu

Hebei University of Chinese Medicine

822053583@qq.com+86 15532168606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026